ADCT short interest
ADC Therapeutics S.A. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,896,051 |
|---|---|
| Change vs prior report | 1,505,484 (+27.9%) |
| Change over six months | +40.7% |
| Days to cover | 4.37 (sector: 3.78) |
| Average daily volume | 1,579,045 |
| Rank in Healthcare | #479 of 922 by days to cover |
ADCT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,896,051 | +27.9% | 4.37 | 1,579,045 |
| 2026-09-15 | 5,390,567 | -14.2% | 3.85 | 1,401,300 |
| 2026-08-31 | 6,285,964 | +1.8% | 2.84 | 2,212,555 |
| 2026-08-14 | 6,175,703 | +21.3% | 6.30 | 979,767 |
| 2026-07-31 | 5,092,137 | -8.0% | 6.11 | 834,025 |
| 2026-07-15 | 5,534,142 | -7.7% | 4.01 | 1,379,837 |
| 2026-06-30 | 5,993,673 | -0.2% | 3.40 | 1,763,741 |
| 2026-06-15 | 6,004,943 | -1.0% | 1.26 | 4,781,581 |
| 2026-05-29 | 6,067,857 | +5.6% | 7.76 | 781,868 |
| 2026-05-15 | 5,747,020 | +5.0% | 3.95 | 1,455,366 |
| 2026-04-30 | 5,474,173 | +6.4% | 5.77 | 949,468 |
| 2026-04-15 | 5,144,704 | +5.0% | 5.62 | 915,959 |
| 2026-03-31 | 4,901,943 | +14.3% | 6.27 | 782,295 |
| 2026-03-13 | 4,290,199 | +4.4% | 3.93 | 1,092,134 |
| 2026-02-27 | 4,108,452 | -5.8% | 4.46 | 920,968 |
| 2026-02-13 | 4,361,953 | -1.3% | 6.83 | 638,445 |
| 2026-01-30 | 4,421,340 | +15.3% | 5.80 | 762,272 |
| 2026-01-15 | 3,833,654 | +7.3% | 5.35 | 716,205 |
| 2025-12-31 | 3,573,570 | -47.2% | 3.24 | 1,102,854 |
| 2025-12-15 | 6,773,739 | +12.4% | 2.58 | 2,629,523 |
| 2025-11-28 | 6,027,937 | +2.7% | 8.66 | 696,331 |
| 2025-11-14 | 5,867,155 | -9.5% | 7.27 | 807,314 |
| 2025-10-31 | 6,480,471 | +1.7% | 8.98 | 721,991 |
| 2025-10-15 | 6,374,485 | +20.3% | 4.87 | 1,307,881 |
| 2025-09-30 | 5,298,345 | +30.2% | 4.58 | 1,156,022 |
import finzdata as yf
yf.Ticker("ADCT").short_interest # every report since 2017
yf.Client().short_interest(["ADCT"], start="2018-01-01")Healthcare short interest · ADCT price history · Who owns ADCT · All short interest